Statement of Changes in Beneficial Ownership (4)
June 03 2020 - 4:30PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
|
1. Name and Address of Reporting Person
*
Carestio Daniel A |
2. Issuer Name and Ticker or Trading Symbol
STERIS plc
[
STE
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Sr VP and Chief Operating Off |
|
(Last)
(First)
(Middle)
C/O 70 SIR JOHN ROGERSON'S QUAY |
3. Date of Earliest Transaction
(MM/DD/YYYY)
6/1/2020 |
|
(Street)
DUBLIN, L2 2
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
| Ordinary Shares | 6/1/2020 | | A | | 4432 (1) | A | $0.00 | 27061 | D | |
| Ordinary Shares | 6/1/2020 | | D | | 747 (2) | D | $165.65 | 26314 (3) | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code
(Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) | 8. Price of Derivative Security
(Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) |
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
| Employee Stock Option (right to buy) | $182.22 | 6/1/2020 | | M | | 26776 | | (4) | 6/1/2030 | Ordinary Shares | 26776 | $0.00 | 26776 | D | |
| Explanation of Responses: |
| (1) | All 4,432 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 3,324 on June 1, 2023 and 1,108 on June 3, 2024. |
| (2) | 747 shares were withheld from the 2,500 restricted shares that vested on June 1, 2020. These 747 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,500 shares were awarded to Mr. Carestio on June 1, 2016. These vested shares were valued at the NYSE closing market price on June 1, 2020. |
| (3) | 19,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,500 on June 1, 2021; 2,712 on May 31, 2022; 1,748 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023 and 1,108 on June 3, 2024. |
| (4) | This option becomes exercisable as follows: 6,694 on June 1, 2021, 6,694 on June 1, 2022, 6,694 on June 1, 2023 and 6,694 on June 3, 2024. |
Reporting Owners
|
| Reporting Owner Name / Address | Relationships |
| Director | 10% Owner | Officer | Other |
Carestio Daniel A
C/O 70 SIR JOHN ROGERSON'S QUAY
DUBLIN, L2 2 |
|
| Sr VP and Chief Operating Off |
|
Signatures
|
| /s/ Ronald E. Snyder, Authorized Representative under Power of Attorney | | 6/3/2020 |
| **Signature of Reporting Person | Date |
STERIS (NYSE:STE)
Historical Stock Chart
From Mar 2024 to Apr 2024
STERIS (NYSE:STE)
Historical Stock Chart
From Apr 2023 to Apr 2024
